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A naturally occurring antisense RNA, transcribed in the opposite direction and complementary tothe envelope transcript, 
was identified in various cell lines chronically infected with HIV-1. In T cells, the antisense transcript is constitutively 
expressed and enhanced by activation with phorbol myristate acetate. The open reading frame corresponding to the 
antisense transcript, when expressed in vitro, encodes a protein with an apparent molecular mass of 19 kDa. Antibodies 
against his protein have been detected in several sera of HIV + individuals and not.in any of the noninfected control sera. 
These results indicate, for the first time, that expression of an antisense open reading frame most likely accompanies the 
HIV infection cycle in humans. © 1995 Academic Press, Inc. 
INTRODUCTION 
Naturally occurring antisense RNA, initially observed 
in prokaryotes, have been shown to participate in the 
control of gene regulation. Antisense control has been 
observed at the levels of transcription, mRNA stability, 
and translation (see Inouye, 1988) and might represent 
an additional general mechanism of controlling gene ex- 
pression. Bidirectional transcription of overlapping genes 
has also been reported in plants (Mol et aL, 1990) and 
in higher organisms (Adelman eta/. ,  1987; Farnham et 
al., 1985; Kimelman and Kirschner, 1989; Lazar et al., 
1989; Munroe and Lazar, 1991; Skeiky and latrou, 1990; 
Spencer et al., 1986; Williams and Fried, 1986). Antisense 
RNA has also been reported in retroviruses such as 
HTLV-1 and HIV-1 (Larocca et al., 1989; Michael et al., 
1994). In 1988, R. H. Miller reported the results of a com- 
puter analysis of the noncoding plus strand DNA of 12 
HIV-1 isolates which indicated a highly conserved ORF 
complementary to the RNA template coding for the enve- 
lope protein. This antisense sequence appeared to be a 
good candidate for transcription owing to the presence 
of eukaryotic promoter elements in the flanking region 
of the ORF (Miller, 1988; Roeder, 1991). In addition, due 
to the presence of signal sequences required for polyad- 
enylation (Birnstiel et aL, 1985; Wickens, 1990; and Fig. 
1A), the antisense transcript might be transported and 
translated as well. This putative transcript would encode 
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a highly hydrophobic protein of 187 amino acids, with a 
relative molecular mass of 20 kDa. The protein would 
be initiated within the highly structured Rev-responsive 
element (RRE) (Malim eta/., 1989) at an AUG located in 
the loop of the most downstream predicted hairpin (L3 
of HIV-1BRu RRE) (Ellerbrok etaL, 1993) and would extend 
through the cleavage site of the Env protein gp160 pre- 
cursor. Here, we present evidence that the antisense 
RNA transcript is present in HIV-l-infected cells and ex- 
pressed in a significant number of HIV + individuals. 
MATERIALS AND METHODS 
Chronically HIV-l-infected and noninfected cell lines 
Both chronically infected T cell lines used in this report, 
8E5 and ACH-2, were kindly provided by T. Folks (CDC, 
Atlanta, GA) and have been previously described (Folks 
et al., 1986; Clouse et al., 1989). Briefly, both the 8E5 
and ACH-2 lymphocytic ell lines were derived from the 
CD2-; CD3-, CD4 + A3.01 clone (a variant of the CEM T 
cell line) (Folks et aL, 1985) as survivors of an HIV-1BnU 
(Wain-Hobson eta/., 1985; Alizon etaL, 1986) acute infec- 
tion. The U1 promonocytic cell line (Folks et aL, 1988) 
was similarly derived after acute infection of U937 cells. 
As reported by Folks and colleagues (1986, 1988, 1989), 
the three cell lines have an integrated provirus and ex- 
press viral particles after phorbol myristate acetate 
(PMA) activation. Nevertheless, the viral particles pro- 
duced by 8E5 cells are not infectious owing to a mutation 
in the polymerase sequence. 
Oligonucleotides and vectors 
The oligonucleotides used for the RT/PCR designed 
to reveal the antisense transcript were all defined ac- 
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cording to the HIVBRu sequence (Alizon eta/., 1986; Wain- 
Hobson eta/., 1985). The 3' sense primer 7101-(5'GGA- 
AGTAGGAAAAGCAATGTAT3') was used for reverse 
transcription and the 5' antisense primer 7210-(5'CAG- 
GTCTGAAGATCTCGGA3') for PCR. Inversely, to reveal 
the sense transcript, the 7210 antisense primer was used 
for RT and 7101 sense primer for PCR. This primer combi- 
nation led to an amplified fragment of 127 bp the specific- 
ity of which was verified with the labeled internal oligonu- 
cleotide 7181 -(5'CCCA-I-FGTTGTTA-i-FACCACCATCTCT- 
TGT3'). The vector used to in vitro transcribe the 
antisense RNA is the pE/kH vector (Ellerbrok eta/., 1993) 
which contains the Pstl-Hindlll 1.95-kb sequence from 
HIV-1BRU cloned into the T3T7 Bluescript KS- vector (Stra- 
tagene) downstream from the T7 promoter. The plasmid 
was linearized with Sacl and T3 polymerase was used 
for transcription of the antisense RNA. Runoff transcrip- 
tion was as already described in detail (Elterbrok eta/., 
1993). 
Detection of antisense transcript: Schematic and 
experimental design of the RT/PCR procedures 
The schematic design of the RT/PCR analyses devised 
to investigate the antisense transcript and, as a control, 
the sense messengers, throughout activation of cells 
chronically infected with HIV-1, is presented in Fig. lB. 
RT/PCR amplifications have been performed on total RNA 
preparations extracted from the control noninfected pa- 
rental A3.01 and U937 and from the HIV-1 chronically 
infected ACH-2, 8E5, and U1 cell lines, at the indicated 
times (see Fig. 2) after PMA activation. For the RT/PCR 
designed to reveal the antisense transcript, 2 #g (T 
lymphoid cells) or 6 #g (promonocytic ells) of total RNA 
was denatured for 20 min at 70 ° in the presence of 0.25 
#M (in a final volume of 100 #l) of the 3' sense primer 
7101. After an annealing step at 42 ° for 30 min, the RT 
reaction was carried out (20 #1) in the presence of 250 
/~M of each of dATP, dCTP, dGTP, and d-I-FP, 10 units of 
RNasin, and 200 units of M-MLV RT (GIBCO BRL). After 
45 rain at 37 °, PCR reaction was performed (100-#1 final 
volume) in the presence of 1 x PCR buffer without MgCI2 
(Promega Corp.), 10% DMS©, 3 mM EGTA, 2.45 mM 
MgCI2, and 0.25 #M of the 5' antisense primer 7210. 
One unit of AmpliTaq DNA polymerase (Promega) was 
added to each sample and the amplification profile con- 
sisted of denaturation at 92 ° , primer annealing at 55 ° and 
extension at 72 °, each for 1 min during 17 cycles for the T 
cells or 30 cycles for the promonocytic ells. Accordingly, 
under these conditions - -  relatively stringent primer con- 
centration and annealing temperature--the magnitude 
0fthe signals remained proportional to RNA concentra- 
tion and number of cycles, making the RT/PCR a semi- 
quantitative procedure. Conversely, to reveal the sense 
transcript he RNA was first transcribed with the 5' anti- 
sense 7210 primer and thereafter amplified with the 3' 
sense 710t primer and processed as just described. The 
size of the products was then determined by 8% poly- 
acrylamide gel electrophoresis in Tris-borate/EDTA 
buffer of 20 #1 of each sample. After transfer, the mem- 
brane was incubated with the labeled internal oligonucle- 
otide 7181 and the product (127 bp) analyzed by autoradi- 
ography. Control experiments without RT, without RNA, 
and in the presence of RNase were also carried out. Ten 
micrograms of all the RNA samples was also analyzed 
for HIV RNA accumulation, throughout activation of the 
cells, by Northern blot experiments as previously de- 
scribed by Serpente eta/. (1992). 
In vitro transcription and translation 
For in vitro transcription of the antisense RNA, 1 #g of 
pE/kH was linearized as described and transcribed in 
the presence of mTGpppG (Ellerbrok eta/., 1993). The 
quality of the RNA preparations was verified on agarose 
gel. The translation was performed in a rabbit reticulo- 
cyte lysate (Promega) as previously reported (Ellerbrok 
eta/., 1993). Incubation was performed in either the pres- 
ence or the absence of pancreatic microsomal mem- 
branes (with no apparent modification of the products) 
for 30 min at 30 ° . Subsequently, the products were ana- 
lyzed by PAGE before or after immunoprecipitation. 
Immunoprecipitation experiments 
The in vitro antisense products were immunoprecipi- 
tated with two antipeptide sera, anti-134 and anti-132 
raised in rabbits against the synthesized peptides 44- 
62 and 121-134, respectively (Miller, 1988). Aliquots of 
translational products (2 X 105 cpm) were incubated in 
200 #1 of the following buffer (500 mM NaCI, 20 mM Tris, 
pH 7.5, 0.5% Nonidet P-40) overnight at 4 ° in the presence 
of 3 #1 of the aforementioned antipeptides as well as 
with the control preimmune serum. Saturating amounts 
of protein A-Sepharose were then added during 1 hr at 
20 ° . The immune complexes were washed three times 
with the same buffer and three times with 150 mM NaC[, 
20 mMTris, pH 7.5, 1% Triton X-100, 0.2% sodium deoxy- 
cholate and analyzed by 10-15% SDS-polyacrylamide 
gel electrophoresis. The translational products were also 
immunoprecipitated with a 2.5% dilution of 15 selected 
HIV-1 + antisera (gift from F. Barre-Sinoussi), 10 control 
noninfected sera, and 10 sera from HIV- individuals with 
viral diseases distinct from AIDS (gift from J. Pillot). The 
immune complexes were processed and analyzed as 
above except that the last three washes were performed 
in the presence of 0.1% SDS. 
RESULTS 
An antisense transcript RNA is present in HIV-1 
chronically infected cells 
A standard Northern blot analysis, using a 32p-labeled 
env riboprobe, was not sufficiently sensitive to detect the 
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FIG. 1. Genetic organization of the antisense gene and experimental design of the RT/PCR procedures. (A) The genetic organization of the newly 
identified antisense transcript is shown in relation with the complementary sense transcript. The Pstl and Hindlll restriction sites in italics indicate 
the boundaries of the env sequence inserted into the Blueseript vector. The ORF sequences are shown as thick strokes, the RRE as a block, and 
both Env and antisense proteins as open boxes. The SUgp120 and TMgp41 are indicated as well as the cleavage site of the Env precursor. The 
initiation, stop eodons, CAT, and TATA boxes are indicated. The sequence of the polyadenylation domain is presented in the lower part with the 
hexameric sequence underlined and the potential po]yadenylation sites are in bold letters. (B) In the schematic design of RT/PCR analysis, sense 
and antisense ORF of the sense and antisense proteins are presented as thick strokes and the RRE domain as a block. Long arrows indicate the 
sense of transcription and small arrows represent he various combinations of sense and antisense primers used for the RT and PCR amplification. 
antisense transcript in total and poly(A) ÷ RNA prepara- 
tions from several T cell lines chronically infected with 
HIV-1 such as 8E5 and ACH-2 cells (Folks et aL, 1986; 
Clouse eta/., 1989) or from U.1 promonocytic ells (Folks 
et al., 1988). However, by using RT/PCR technology, as 
described in the legend to Fig. 1B, the antisense tran- 
script was detectable in all three cell lines. We used a 
RT/PCR-coupled standard protocol in which the reverse 
transcriptase activity contained in various Taq polymer- 
ases (such as Perk in -E lmer -Cetus  or Promega Corp.) 
was abol ished by the addition of 3 mM EGTA to the 
PCR reaction (Myers and Gelfand, 1991). Under these 
conditions, no hybridization signal was observed in the 
absence of added RT (Fig. 2, RT -a and RT -b) which pro- 
vided assurance that the RNA preparations were not con- 
taminated with residual DNA, whose presence could in- 
terfere with the results. The controls without RNA were 
negative and RNase treatment of the RNA preparations 
completely abol ished the signal (data not shown). As 
expected, after RT/PCR performed in the order of first 
the 5' antisense 7210 and second the 3' sense 7101 
ol igonucleotides, a major amplif ied fragment of 127 bp 
(Fig. 2) was observed. This 127-bp amplif ied fragment 
indicates the presence of the normal sense transcripts 
(env and genomic RNA) in the RNA preparations from 
the HIV-infected cell lines. The kinetics of expression of 
the sense transcripts revealed by semiquantitative PCR 
were in good correlation with the kinetics and the level 
of mRNA accumulation observed in ACH-2 and 8E5 cells, 
as demonstrated previously by Northern blot analysis 
ANTISENSE RNA AND PROTEIN IN HIV-I-INFECTED CELLS 199 
A A3.01 ACH-2 





8E5 B U937 U1 
0 6 24 hr 0 0 hr 
4,2 kb Northern 
blot ~ 28 a 
2kb 
2kb 
RT _° RT .b 
[ ]  -'.l--- 127 bp Sense D [ ]  ~ -q=---127 bp 
transcript 
RT .a RT .b 
~ "P--- 127bp Antisense D ~ ~ "P-- 127bp transcript Antisense transcript 
FIG. 2. Analysis of the antisense RNA transcript. The kinetic expression of the antisense transcript was analyzed by RT/PCR (see Materials and 
Methods) and compared to that of the sense transcripts revealed by RT/PCR and Northern blotting. (A) RT was achieved with 2 #g of total RNA, 
extracted at different times after PMA activation, from noninfected A3.01 or HIV-1 chrenically infected AOH-2 and 8E5 cell lines. PCR was performed 
during 17 cycles. RT -~ represents one of the controls without RT carried out with RNA from ACH-2 extracted 6 hr post activation. Ten micrograms 
of all RNA samples was also analyzed forsense H IV RNA accumulation, throughout activation of the cells, by Northern blot experiments as previously 
described (Serpente t al., 1993). (B) The RT was performed with 6 #g of total RNA from.the U937 and U1 cells prepared prior to activation and
amplification was during 30 cycles. RT -b represents the control without RT. Also, 10 #g of RNA was analyzed by Northern blotting. The black arrows 
indicate the size of the specific amplified products andof the sense HIV transcripts. The upper right arrow points to the 28S RNA. A and B were 
produced by digital scanning of original autoradiographs. 
(Serpente et aL, 1992, 1993; and Fig. 2A). The sense 
transcript was absent in the A3.01 control noninfected 
cells. In addition, under the RT/PCR conditions designed 
to demonstrate the presence of the antisense transcript 
(see Fig. 1B and Materials and Methods) with the same 
01igonucleotides, the 3' sense 7101 primer being used 
for reverse transcription, the antisense fragment of 127 
bp was present at a basal level prior to activation. PMA 
treatment of the HIV-infected T cells (Fig. 2A) increased 
the level of the antisense RNA. However, it is noteworthy 
that even though the same two primers were used to 
reveal sense and antisense transcripts, the efficiency of 
RT priming varies from one primer (7101) to the other 
(7210) and thus the magnitude of the signals does not 
reflect he relative concentration of sense and antisense 
transcripts. We also observed that the antisense tran- 
script was present in the HIV-1 chronical ly infected U1 
promonocytic ell line prior to PMA activation, at a time 
when the partially spliced and full-length sense tran- 
scripts were barely detected by Northern blot and RT/ 
PCR (Fig. 2B). 
The antisense transcript is capable of encoding a 
protein in vitro 
We analyzed the coding capabil ity of the HIV-1BRu anti- 
sense ORF in an in vitro reticulocyte tysate translation 
system utilizing the antisense RNA transcript derived 
from the pE/kH T3T7 Bluescript vector (Ellerbrok et aL, 
1993). This antisense transcript exhibits only one signifi- 
cant ORF (in the three frames) which may encode a pro- 
tein with a relative molecular mass of 20.6 kDa calculated 
from the deduced amino acid sequence of 189 residues, 
slightly different from the consensus sequence reported 
by Miller (1988). Translation of the in vitro-synthesized 
antisense RNA (see Materials and Methods) yielded a 
major band with an apparent molecular mass of 19 kDa 
(Fig. 3A) in good agreement with the relative molecular 
mass of the 20.6-kDa putative protein. Several minor 
bands were also observed and, in particular, a 50-kDa 
product which may arise by aggregation of the antisense 
protein when the concentration of the antisense messen- 
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FiG. 3. Analysis of the in vitro-synthesized antisense protein. (A) 
Increasing amounts of in vitro-synthesized antisense transcript (lanes 
4 to 2) were translated in a reticulocyte lysate. The products were 
analyzed by 10-15% polyacrylamide gel electrophoresis. Lane 1 corre- 
sponds to the control of translation in absence of RNA. The arrows on 
the right indicate the apparent molecular mass of the major 19-kDa 
product (ASP) and that of a minor product appearing when the RNA 
concentration was increased. (B) The translational products were im-
munoprecipitated with two antipeptides, anti-134 (lane 3) and anti-132 
(lane 4) raised in rabbits against the 44-62 and 121-134 synthesized 
peptides (Miller, 1988). Lane 5 represents the control of immunoprecipi- 
tation with a preimmune serum, lane 2 represents the products prior 
to immunoprecipitation, and lane 1 corresponds to the control of trans- 
lation in absence of RNA. A and B were produced by digital scanning 
of original autoradiographs. 
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FIG. 4. Analysis of the ability of HIV + sera to immunoprecipitate the 
ASP, The in vitro-synthesized products were immunoprecipitated with 
2,5% dilution of 15 well-characterized HIV-1 + sera (lanes 2-16). Lane 
1 corresponds to the translational products prior to immunoprecipita- 
tion, The arrows point to the antisense protein (ASP). l, III, and IV refer 
to the stage of HIV infection, The figure was produced by digital scan- 
ning of an original autoradiograph. 
ger was increased. To ascertain that the 19-kDa major 
protein was correctly initiated, two oligopeptides (44-62 
and 121-134) were synthesized, corresponding to the 
two hydrophilic domains of the protein deduced from 
the antisense ORF sequence (Miller, 1988). Polyclonal 
antibodies were raised in rabbits against the two pep- 
tides, and both antibody preparations recognized the 19- 
kDa antisense protein produced in vitro (Fig. 3B, lanes 
3 and 4); a preimmune rabbit serum was negative (lane 
5). The specificity of the antipeptide was verified by com- 
petition experiments carried out with specific and irrele- 
vant peptides (data not shown). Hence, the antisense 
transcript RNA is accurately initiated and could encode 
in vitro an antisense protein (ASP) of 19 kDa, with the 
correct amino acid sequence as predicted from the anti- 
sense ORF. 
Antibodies against the antisense protein were 
detected in sera from HIV-1 + individuals 
The natural occurrence of the antisense transcript in 
the HIV-1 chronically infected T cell lines led us to exam- 
ine the possibility that the antisense 19-kDa protein was 
produced in these cells. Use of polyclonal antipeptide 
sera yielded extensive background bands in noninfected 
cells, and thus did not allow conclusive identification of 
the ASP in the infected cells. As a consequence we are 
in the process of preparing antibodies against the intact 
antisense protein. We also examined the possibility that 
the 19-kDa antisense protein was produced during natu- 
ral HIV-1 infection by analyzing the ability of antisera 
from control and HIV + individuals to recognize the in 
vitro-synthesized protein. Figure 4 shows that several 
HIV + sera were able to immunoprecipitate the antisense 
protein whereas sera from 20 HIV- control individuals 
with or without viral diseases distinct from AIDS did not 
react with the protein (data not shown). 
DISCUSSION 
The RT/PCR data presented here indicate that a region 
of the plus strand DNA of the HIV-1 provirus is capable 
of being transcribed as an antisense RNA, in cells of 
both lymphoid and macrophagic origin chronically in- 
fected with the HIV-1BRU isolate. This antisense RNA is 
complementary to the env RNA sequence and encom- 
passes the cleavage site of the Env gp160 precursor. 
Michael and colleagues (1994) also reported the pres- 
ence of transcripts complementary to the gag and nef 
coding sequences in HIV-infected cells, using a similar 
RT/PCR approach. They cloned a cDNA corresponding 
to a transcript of 2242 nucleotides, whose antisense 
"negative-st'rand promoter" (NSP) was proposed to be 
located within the 3'LTR. The sequence derived from the 
cDNA clone of Michael et al. (1994) showed that this 
antisense transcript was polyadenylated, although sur- 
prisingly, immediately downstream of TGA, with the poly- 
adenylation signal located within the coding sequence. 
Another polyadenylation signal was mapped 11 nucleo- 
tides 3' of the stop codon by RT/PCR experiments (data 
not shown). These data suggest the presence of different 
termination sites for transcription generating mRNA with 
alternative 3' ends, as frequently encountered among 
eukaryotic messengers. 
We have also observed that, in the ACH-2 and 8E5 T 
cells, the level of the antisense transcript was always 
lower than that of the sense transcripts, since unlike 
the sense transcripts the antisense mRNA was never 
detected by Northern blotting. This is in agreement with 
results showing a lower promoter activity of the NSP with 
respect to the positive strand promoter (PSP), at least 
after transfection of various cell lines with CAT vectors 
under the control of either promoter (Michael et aL, 1994). 
Moreover, our experiments showed that the antisense 
messenger steady state was modulated upon cellular 
activation. Indeed, in both chronically infected T cell lines 
the antisense transcript was markedly increased upon 
PMA activation as was the sense mRNA. While the anti- 
sense mRNA could be readily detected in the Ul pro- 
monocytic cell line prior to activation, the level of the 
antisense transcript was repeatedly shown to be lower 
than the level observed in the T cells, as has also been 
noted for the sense transcripts (Serpente et aL, 1992). 
Upon activation of promonocytic ells, preliminary results 
indicate that, whereas the sense RNA increased (Ser- 
pente et al., 1992), the level of antisense transcripts de- 
clined in contrast to the PMA-mediated increase ob- 
served in T cells. 
Because the sense and antisense transcripts ap- 
peared to be expressed simultaneously in the HIV-1 
chronically infected cells, it is possible that these tran- 
scripts exist in the nucleus and/or cytoplasm as an RNA 
duplex involved in the control of expression of sense and 
antisense RNA counterparts. Accordingly, the potential 
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sense/antisense RNA duplex formation might have a reg- 
ulatory function in the maturation and/or stability of the 
sense transcripts and/or in the synthesis of the sense 
proteins and vice versa. In addition, since the activity 
of NaP and PSP might fluctuate divergently throughout 
cellular activation, the ratio of mRNA counterparts could 
vary from quiescent to activated states. The variation of 
the ratio, as shown for antisense and sense gag tran- 
scripts in early stage HIV-l-infected patients (Michael et 
al., 1994), might therefore constitute a sophisticated way 
of controlling HIV gene expression..Moreover, due to 
the increasing number of reports on naturally occurring 
antisense transcripts (Adelman et al., 1987; Kimelman 
and Kirschner, 1989; Lazar et al., 1989; Munroe and La- 
zar, 1991; Skeiky and latrou, 1990; Spencer et aL, 1986; 
Williams and Fried, 1986), one can postulate that endoge- 
nous antisense regulation may be one of the normal 
components of gene regulation in eukaryotes. 
In contrast to most of the reported naturally occurring 
antisense transcripts, the HIV-1 antisense RNA de- 
scribed here includes a significant OAF. Indeed, its OAF 
is capable of encoding a protein (ASP) of 189 aa in vitro, 
recognized by two different antipeptides raised against 
the two hydrophilic domains of the putative protein and 
therefore corresponding to the protein predicted from the 
antisense sequence. 
Interestingly, this antisense protein appeared to be 
produced in humans during the HIV-1 infection cycle 
since several sera of HIV-1 + individuals, unlike control 
sera, recognized the in vitro-synthesized antisense pro- 
tein. Therefore, in addition to the potential control exerted 
by the antisense transcript itself, its capacity to serve 
as a template may furnish a corresponding protein and 
provide an additional element of gene control. Neverthe- 
less, it might rather represent an additional structural 
protein of the viral particle, its highly hydrophobic nature 
suggesting potential membrane association (C.V-B. and 
C.V., personal communication). 
Finally, it should also be noted that the initiation codon 
0fthe antisense protein is located within the ARE struc- 
ture and more precisely in the L3 loop (Ellerbrok et al., 
1993) which we found to play a role in the regulation 
0ftranslation of the gp160 Env protein. Intriguingly, an 
antisense OAF complementary to the 3' extremity of the 
envcoding sequence was evidenced in the FIV sequence 
by computer analysis (C.V., M. Sitbon, and G. Pancino, 
personal communication). In this retrovirus the ARE, re- 
ported to play the role established for the ARE of HIV, is 
also located at the 3' end of the env sequence (Phillips 
eta/., 1992). This is of some significance due to the key 
r01e played by this regulatory element as a binding site 
of the Rev protein which is involved in various steps of 
HIV-1 regulation, from transcription to translation (Arrigo 
and Chen, 1991 ; Cochrane et al., 1991 ; D'Agostino et al., 
1992). The use of both strands of the same DNA se- 
quence to generate complementary sense and antisense 
RNA might provide an additional control to the circuit 
that regulates Env expression. 
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